摘要
提供假药罪的行为主体为持续或临时具有用药权限的单位及其中具有药品管理使用权限的人员。对该罪中假药的认定应采实质认定标准,紧扣对个人法益的侵害,且与生产、销售假药罪中的假药在认定上不能机械地等同,而应达到“足以严重危害人体健康”的程度。在提供假药罪的明知认定方面,应充分结合既往司法实践、相似规定和刑法理论来对司法解释所规定的各项情形予以解读。提供假药罪中的“使用”是指以提供给他人使用为目的,且仅指直接药用;同时,应以用药人是否存在以给付行为为标准,对“无偿”作实质认定。
The subject of the crime of providing counterfeit drugs are the units with continuous or temporary drug use authority,and the personnel in the units with the drug management and use authority.Determination of"counterfeit drugs"in the crime of providing counterfeit drugs should adopt the substantive identification criteria,which is tightly related to the infringement of personal legal interests,and cannot be mechanically equivalent to the identification of counterfeit drugs in the crime of producing and selling counterfeit drugs,and should reach the ex-tent of"enough to seriously jeopardize human health".In the aspect of knowledge cognizance of the crime of provid-ing counterfeit drugs,we should fully combine the previous judicial practice,similar provisions and criminal law theory to interpret the various situations stipulated in the judicial interpretation.In addition,the term"use"in the provision of the crime of providing counterfeit drugs refers to the purpose of providing them to others for use,and"use"only refers to direct medicinal use.At the same time,the substantive determination of"free"should be deter-mined based on whether there is payment behavior of the drug user.
作者
雷英君
邓毅丞
Lei Yingjun;Deng Yicheng
出处
《医学与法学》
2023年第6期17-25,共9页
Medicine and Jurisprudence
关键词
提供假药罪
假药
实质认定标准
the crime of providing counterfeit drugs
counterfeit drugs
substantive identification criteria